Assault on the male. by Twombly, R
Fous
According to Tom Bruckman, men and
women are not created equal-when it
comes to researching the sex-specific cancers
that strike and kill them. In 1994, the
National Cancer Institute spent five times
more ($267 million) studying breast cancer
than prostate cancer ($57 million), points
out Bruckman, the executive director ofthe
American Foundation for Urologic Disease.
But the fact that prostate cancer is now the
number one cancer detected in men, and the
number two cause of cancer deaths among
men, has begun to mobilize its victims.
"Support groups have exploded into action,"
says Bruckman. "Four years ago, there were
about 10 groups across the country. Now
there are almost 500. We are learning from
the experience women have had in lobbying
for research and in helping themselves out."
The facts are indeed scary. Not only is
the rate ofprostate cancer growing in elderly
men (it accounts for 92% of male cancers),
but its brother, testicular cancer, is also
increasing (its incidence has doubled in the
last 50 years), and is now the most common
malignant disease in young men. And then
there is the ongoing, ominous debate about
falling sperm levels.
But the sex-selective cancers do share
some depressing similarities. This year, more
than 244,000 men will be diagnosed with
prostate cancer, and about 40,000 will suc-
cumb. About 183,000 women will develop
breast cancer, and 46,240 will die. Other
sex-selective cancers such as cancer of the
cervix, ovary, and uterus, will account for
26,400 deaths, while testicular and other
on the
male reproductive cancers and is the substance that makes the 1.5-inch
will kill 580 men annually. walnut-shaped prostate develop and stimu-
Breast cancer can affect lates it to manufacture secretions for sperm.
one in eight women, if The question for researchers is which men
they live long enough, are at risk for cancer of their reproductive
and 13% of men develop system
and why.
clinically significant
prostate cancer at some AFat Risk?
time in their lives, usually Like any good mystery, there are many clues
late in life. The NCI says leading researchers down disparate avenues,
that every 3 minutes, a new often to contradictory evidence. "I don't
case of prostate cancer is diag- know if any one theory holds the truth or is
nosed in the United States, and flawed," said Johns Hopkins Urologist-in-
every 15 minutes a man dies ChiefPatrick Walsh. "All we can say is that
from it. One-third ofthemwlll there are a number of intriguing leads, so
5A1teventually die from the disease, nothing should be dismissed."
according to theNCI. The first clue to teasing apart influences
The statistics are bad on prostate cancers is population studies that
enough, says Bruckman, but what really revealed up to one-third ofall men examined
scares men is the knowledge that after age at autopsy are found to have microscopic,
45, the prostate starts changing. No one can incidental prostate cancer. And this 30%
predict ifthat transformation will result in a incidence is found in men around the world,
painful, but cancer-free, enlargement or a so it is likely caused by some universal factor
slow-growing carcinoma that, when it finally such as age. In some men, this latent cancer
produces symptoms, is often too advanced never becomes a problem, but in others it
to cure. Metastasized prostate cancer is fatal kills them. Death rates vary dramatically
because chemotherapy can't target the slow- from country to country. A 1982 study by
growing carcinoma. Prostate cancer increas- the International Agency for Research on
es faster with age than any other major can- Cancer, in Lyon, France, looked at prostate
cer; researchers have found that by age 80, cancer incidence in five continents and
approximately 60-70% of men have evi- found a25-fold difference between incidence
dence of incidental carcinoma at autopsy. rates in black American men living in San
By the year 2000, the incidence of prostate Francisco and Japanese men. In 1990, a
cancer is expected to increase by 90%, and team from Johns Hopkins, led by urologist
deaths will rise by 37%. John Isaacs, further refined the comparison,
What prostate cancer shares with breast conduding that the initiation rate ofprostate
cancer, according to Stanford epidemiologist cancer was the same in Japanese and
Alice Whittemore, a leading prostate cancer American men, but that there appeared to be
researcher, is that "there are no neat models differences in the rate ofpromotion or pro-
to tie all the risk factors together: those things gression to clinically evident prostate cancer.
you eat, are exposed to, and how yourgenetic Their observations were supported by other
disposition handles everything. We know so studies that found that immigrants who
little about what causes these _ move from low-risk areas to the
diseases." J United States assume Ameri-
This is also true of testicu- cans' higher risks.
lar cancer. Although cancer of -= So what are the risk factors
the testis is a disease of young that increase the chance of the
men and is highly treatable, cancer progressing in American
researchers don't know what men, but cause very few
causes it, or even ifit is related Japanese men to die of prostate
in some fashion to other male cancer? One obvious environ-
genital cancers. The glands icWIb* Groc mental culprit is the fatty
share hormonal influences. linkages may soon 0p00 Western diet, which is said to
Testosterone, the male hor- vide insights into prostate contribute to a number of can-
mone, is made in the testicles cancer. cers, including breast and colon,
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colon, but not testicular. As early as 1975,
researchers found that prostate cancer death
in 32 countries was highly associated with
total fat consumption, a finding similar to
that forbreast cancer. Follow-up studies have
also made the case for diet. A 1993 Harvard
study of48,000 men found that those men
who consumed high amounts of saturated
and unsaturated fats had the highest risk of
ending up with advanced or fatal cases of
prostate cancer, but there was no association
between fat intake and early
stages ofprostate cancer. Taking
these findings a step further, the
research team, led by Edward
Giovannuci and Walter Willett,
discovered a link between the
disease and a type of fat called
alpha-linolenic acid, which is
found in meat as well as in dairy
products andotherfoods.
This May, results of a four-
year case-control study of
prostate cancer among men of
different ethnic and racial back-
grounds living in five locations confirmed
that fat is a risk factor for advanced cancer,
but this time it was saturated fat. The study
led Stanford's Whittemore to conclude that
there is a "causal role in prostate cancer for
saturated fat intake, but the data suggest that
other factors are largely responsible for
interethnic differences in risk. Fat is definite-
lyafactor, but there are others," shesays.
Researchers are also studying ways that
fat could promote cancer. Some say it may
dramatically affect prostate cell membranes,
altering them in such a way that cells are
more likely to turn cancerous. Another theo-
ry is that a diet high in animal fat raises a
man's level of testosterone, which in turn
bolsters the likelihood that cancerous cells
will multiplyand form a tumor.
The answer is notsimple. Forexample, a
high-fat diet is believed to play a role in
other diseases, such as colon and breast can-
cer. The death and incidence rates of
prostate cancer are higher among American
blacks than American whites, yet the inci-
dence of breast and colon cancer is about
the same in the two groups. Iffat is the cul-
prit, why isn't the rate ofprostate cancer as
high inwhites?
Other researchers point to different
aspects ofthe diet that could influence can-
cer. An experiment reported in the March 1
issue of the Journal ofthe National Cancer
Institutefound modified citrus pectin, given
orally to rats, inhibited spontaneous metas-
tasis in prostate cancer. The researchers,
from the Michigan Cancer Foundation and
University ofMichigan School ofMedicine,
found that modified citrus pectin, acomplex
polysaccharide, inhibited the adhesion of
prostate cancer cells to rat endothelial cells.
In other labs, scientists have linked deficien-
cies in vitamin A, a fat-soluble vitamin
found in yellow vegetables, to development
ofdifferent kinds oftumors. But the type of
vitamin A seems to matter: supplements of
one kind ofvitamin A, beta-carotene, found
in certain vegetables, appear to lower risk of
prostate cancer, while other forms of vita-
minA, found in animal fat, raise it.
Another vitamin seems to be related to
geographic incidence of
E prostate cancer. A 1992 study
in the journal Cancer demon-
strated a global north-south
graduated pattern of prostate
cancer, with the highest rates
in the north. The theory
explored bythe authors, Carol
Hanchette and Gary Schwartz
of the University of North
Carolina at Chapel Hill, is
that insufficient levels ofvita-
min D from UV radiation
may increase the chance ofthe
cancer. It could explain a number ofobser-
vations, say the authors, such as why more
men in the Scandinavian countries, Canada,
and the United States have prostate cancer
than men in Asia, and why black men are
susceptible-people with dark skin absorb
less sunlight and thus have lower levels of
vitamin D.
Genetic Mechanisms
There are some clues about the inheritability
of prostate cancer. A 1992 study by Johns
Hopkins researchers Bob Carter and Patrick
Walsh, published in the 15 April 1992 issue
ofthe Proceedings ofthe NationalAcademy of
Science, showed for the first time the dose
association between a family history of
prostate cancer and a man's likelihood of
developing the disease early in life. Says
Walsh, "Your risk of the disease is twice as
high ifyour father or brother has it. But the
risk could grow to 90 percent depending on
the number of affected relatives you have
and the age at which they develop the dis-
ease." But researchers say this familial form
of prostate cancer probably accounts for
only about 10% ofthe cases, similar to the
inheritability ofbreast cancer. And they sus-
pect it is autosomal dominant-a single
gene from the mother or father can lead to
development of disease. But the "prostate
gene" has not been mapped yet. "I think
genetic linkages are bound to give us paydirt
soon, but there are a number of interesting
leads on environmental factors, as well," says
Walsh. "Nothingshould be dismissed."
Late last year, researchers in another
Johns Hopkins laboratory identified a genet-
ic alteration linked to prostate cancer that
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they believe is the most frequently occurring
genetic error associated with the disease. In
almost all ofthe human prostate cancer sam-
ples he studied, oncologist and urologist
William Nelson found deactivation of the
gene that codes for glutathione S-transferase
(GSTPJ), an enzyme that detoxifies envi-
ronmental carcinogens. He also found that
some men with noncancerous prostate
tumors produce the enzyme while others
don't, indicating that alteration of the gene
may cause the tumors to become cancerous.
Nelson noted that diet and genes may form
an "alluring" nexus in this situation:
"Vegetables like broccoli and brussel sprouts
trigger high production of these enzymes."
Inherited gene mutations likely speed up
initiation of the cancer, and environmental
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events may promote it or pro-
tect against it, Nelson says.
In May, a major gene dis-
covery offered the hope of a
test to predict the course of
prostate cancer in individuals
and hope of corrective gene
therapy. Johns Hopkins re-
searcher John Isaacs and Carl _
Barrett, head of the NIEHS's -
molecular carcinogenesis labo-
ratory, identified a gene, called
KAII, that prevents prostate
cancer cells from metastasizing, or spreading
out from the gland. It is only the second
human gene known to block deadly metas-
tasis. The gene's action had been shown in
mice injected with human prostate cancer.
According to Barrett, the research team first
proved that metastatic prostate cancer cells
lacked the KAII gene, but that it was pre-
sent in prostate cancers that didn't spread.
The gene was isolated, injected into cultures
of human prostate cancer cells, and then
transferred to mice. These mice had much
less cancer spread than mice without the
gene. "We don't know how this gene affects
the invasive ability of cells, but it is quite
unique. Most genes found to date in cancer
regulate the growth of cells," says Barrett.
"We want to identify what factor, potential-
ly environmental, that causes the gene to
turn off." Currently, Barrett is trying to
determine whether K4I1s effects are limited
to prostate cancer, and the Johns Hopkins
team is looking to see ifthe KAJI gene was
absent in cancer that spread in 200 prostate
cancer patients.
There have been few leads on the genet-
ic influences of testicular cancer, which is
expected to be diagnosed in 7,100 American
men this year, killing 370. No clear abnor-
malities in known oncogenes or tumor-sup-
pressor genes have been linked to testicular
cancer, according to University of Chicago
urologist Robert Smith. Smith reported in
May in theJournal ofUrology that evidence
from his laboratory points to the possibility
that one or more tumor-suppressor genes
are inactivated on chromosome 11, near
where a tumor-suppressor gene for Wilms'
tumor, a cancer of the kidney that particu-
larly affects children, and for gonadoblas-
tomas have been found. Smith said it
appears that these genes may be important,
although "it is likely that testicular cancer
results from a multistep process involving
alterations in many genes.
Many scientists point to abnormalities in
the development ofthe testes as a risk factor.
Research at Oxford University found 32% of
patients with the cancer had atrophy of the
testis, and 75% may have reduced sperm
count. These results point to another pre-
dominant risk category for
^ both testicular and prostate
- cancer: natural and synthetic
C estrogens.
Hormonal Balance
The first hint that the level of
sex hormones circulating in
men had an impact on male
reproductive cancer was the
observation that prostate can-
cer is rarely found in men
with undeveloped testes and
in castrated men. The evidence has since
been stacking up to form an alarming pic-
ture that paints estrogen and testosterone as
cancer culprits.
The prostate and the testes are regulated
bysex hormones called androgens, which are
made in the testes. Foremost among these
hormones is testosterone, produced in the
testes but controlled by a hormone from the
pituitary gland, called luteinizing hormone
(LH). Testosterone circulates in the blood
and enters the prostate gland by diffusion,
where it is transformed by an enzyme into
the hormone dihydrotestosterone (DHT),
which is more than twice as potent as testos-
terone. Both hormones can bind to the same
receptors on the prostate cell, which activates
genes. During this process, the hypothala-
mus monitors the amount oftestosterone in
the blood and boosts or cuts back on pro-
duction of LH. Estrogens can promote or
retard the process naturally, but the precise
mechanisms of how a hormonal imbalance
leads to cancer is not yet understood.
Environmental estrogens mimic the action
of natural estrogens; they have the same
chemical key that can turn hormone produc-
tion on oroff.
Conversely, estrogen receptors can be
blocked by weak estrogen impostors that
block sex hormone production. The result
could be falling sperm counts, as found in
1992 by Danish researchers who performed
a meta-analysis of 61 studies worldwide,
and concluded that mean sperm concentra-
tions have been cut almost in half between
1940 and 1990. The world's attention was
riveted to the finding, especially
when University of Florida
researcher Louis Guillette, who
reported similar findings in alli-
gators, told a congressional
committee, "every man in this
room is halfthe man his grand-
father was." But the Danish
findings are controversial; some
scientists analyzed the same
data and found increasing -
sperm counts, while others say
sperm production can be affect-
ed by venereal disease, and the
difference in rates of venereal disease may
account for the findings.
Another theory is that prenatal exposures
to estrogens are responsible for rising num-
bers of testicular cancers. That link was
explored byJohn McLachlan, director ofthe
Center for Bioenvironmental Research at
Tulane University, who found several
decades ago that the synthetic estrogen
diethylstilbestrol disrupted fetal testicular
development, producing undescended testes
and lower sperm counts. Since then,
researchers have found dozens of chemicals,
from pesticides to the plastic resin that lines
food cans, that may disrupt the endocrine
system via the estrogen receptor, and further
investigation has found that estrogen mimics
may act in different ways, producing various
responses. The pollutant DDT has been
found to produce testicular cancer in male
rodents, while exposure to PCBs produced
enlarged testes and increased sperm produc-
tion in laboratory rats. Rex Hess, the
University ofIllinois researcher who reported
growth of the enlarged testes at this year's
meeting ofthe Society ofToxicology, says he
thinks there is a critical window in male
development where even a small extra
amount of estrogen will produce delayed,
harmful effects. "If you expose the organ to
estrogen before it is ready, the organ may be
impaired so that it can't function normally in
adults. The toxic effectwould be delayed."
In that context, some research findings
make sense. For example, one study found
thatyoung black men had serum testosterone
levels that are 15% higher than their white
counterparts, accounting for their increased
risk ofdeveloping the cancer. Similarly, other
research determined that pregnant black
women consistently had higher levels of
estrogen than white pregnantwomen.
Gail Prins, a reproductive physiologist at
the University of Illinois, has shown how
excess estrogens can affect the prostate gland.
Prins administered a single high dose of
estrogen to rats on days one, three, and five
after their birth, a critical time during devel-
opment ofthe rat prostate gland (analogous
to the second and third trimester in
humans). She found a majori-
_e _t'@, ty of the rats later developed
prostate cancer. "This makes a
compelling case, as much as
you can make an analogy
between rodent and human
uterine exposure ofestrogen,"
says Prins. She is now trying
F to uncover the actual mecha-
nism-perhaps growth factors
or increased DNA transcrip-
tion-by which early estrogen
exposure leads to prostate
damage.
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On the other hand, the dangers of no
estrogen exposure have been revealed in an
estrogen knock-out mouse produced in the
NIEHS lab of Ken Korach, chief of the
Receptor Biology Section. The consequences
for both genders of the knock-out mouse
was a tendency to infertility, Korach found.
"It had a dramatic effect on the testes, reduc-
ing them to one-half their normal size in
adult males. This means that estrogen has a
real role in male reproduction." Korach has
found that animals exposed to too much
estrogen during a critical period of genital
development have reduced sperm counts:
"It's possible that the estrogen feedback sys-
tem is disrupted, and sperm production is
suppressed," he says. But Korach cannot yet
say that estrogen balance is emerging as a
primary actor in prostate or testicular cancer.
"Right now, it should be considered a possi-
ble player."
Several highly publicized
studies in the late 1980s
reported that men who had
vasectomies were more likely
to develop prostate cancer
because of high levels of
testosterone circulating in the
blood. But more recent data
have discounted that argu-
ment, attributing the rates to
better reporting as these men
were more likely to see physi-
cians about urologic complaints.
The hormonal surge brought on by fre-
quent sexual activity is also a risk factor,
physicians at the Harvard School of Public
Health reported in the May 20 issue of the
British MedicalJournal. Frequent sex trig-
gers excess testosterone and DHT produc-
tion, which promotes cell division in normal
prostate functioning. Harvard physician
Christos Mantzoros says in the report that
high DHT levels might spur cancerous cell
proliferation. Based on the fact that men
who cannot produce DHT never develop
prostate cancer, the NCI is now sponsoring
an 18,000-patient trial of the drug finas-
teride, which controls noncancerous prostate
enlargement bycontrolling DHT levels.
Hormone-modulating chemicals, such as
dioxin, a by-product ofwood-pulp bleach-
ing, seem to work in other sinister ways.
Dioxin appears to affect both the prostate
and the testes because it decreases, by up to
80%, "the amount of sperm available to
ejaculate," says University ofWisconsin toxi-
cologist Richard Peterson. "Sperm produc-
tion is slightly lessened, but sperm storage is
greatly hampered. And the most robust
effects occur at the lowest levels. Dioxin is in
a class ofchemicals that merit more research
because there is already a certain background
level in utero and through lactate exposure."
According to Korach, "Dioxin also alters
liver steroid metabolism, resulting in a possi-
ble hormonal imbalance."
Risky Business
Some researchers are questioning how a
man's occupation might affect his reproduc-
tive health. Research this year from the
Memorial Sloan-Kettering Cancer Center
suggested extreme high (above 800F) and
low temperatures (less than 600F) over a
number ofyears during work may be a risk
factor for testicular cancer, since the testis is
a temperature-sensitive organ. The study,
presented in the Archives ofEnvironmental
Health, found a significant risk factor for
men exposed to high temperatures in their
work environment for more than 10 years.
And a study presented in 1994 from Kansas
State University said that farmers in that
state were at significandy higher
z risk for some cancers, including
prostate cancer. The researcher,
R Scott Frey, told participants
at the American Public Health
Association meeting that data
on almost 70,000 farmers indi-
cate that there may be some-
thing in the farm environment,
such as pesticides, that increases
their cancer risk. But he added
the results are preliminary, and
more research is needed to
assess the full scope of underlying causes of
the cancer risks that Kansas farmers face.
Finally, several studies have looked at
whether the trace mineral cadmium, found
in welding shops, increases the risk of
prostate cancer by reacting with zinc; the
prostate has the highest concentration of
zinc of any organ in the body. Michael
Waalkes, a researcher at NCI's Frederick
Cancer Research and Development Center,
has found that both a rat's prostate and
testes are sensitive to the chemical, which
can cause cancer. But, Waalkes says he can't
yet make the leap to saying that human
glands are damaged. "It's difficult to say
what portion ofthe rat prostate is analogous
to the human prostate, so I don't think there
is a good rat model there. And there is no
good animal model for testicular cancer."
"All in all, I think that both of these
male cancers are multifactorial diseases," says
Waalkes. Like all researchers who seek to
solve these complex biological riddles, he
says the real question is which risk factor is
the most important. Figuring this out will
require continuing basic research into both
male and female reproductive biology and
toxicology to understand howenvironmental
chemicals mayexert their influence.
ReneeTwombly
The gene that codes for an enzyme
that detoxifies environmental car-
cinogens is deactivated in almost all
human prostate cancers. A gene that
prevents the spread ofprostate cancer
hasbeenfoundtobeabsentinanimals
withmetastaticprostatecancer.
Exposure to environmental estro-
gens, particularly in utero, from
pesticides, plastic resins, and other
sources may disrupt the endocrine
system, causing prostate and testicu-
larcancers.
Certain occupations may carry
higher risks for male reproduc-
tive cancers: extreme high and low
temperatures mayplayarole in testic-
ular cancers, and exposure to cadmi-
um and zinc in welding shops may
increaseriskforprostatecancer.
W hereamanlivesmayhavealot ) lvlto do with his risk for prostate
cancer: ethnic groups with high-fat
diets show higher rates ofincidence,
and men who live in northern cli-
mates and receive insufficientlevels of
vitamin D from UV radiation have
higherrates.
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